ClinicalTrials.gov
public full text
Public Domain
A Phase I Single Center Study Evaluating 68GA-FAPI-46 PET/CT in Patients With Interstitial Lung Disease
The purpose of this research is to better understand the distribution of an investigational radioactive imaging agent called 68Ga-FAPI-46 in the lungs of people with interstitial lung disease (ILD) during a Positron Emission Tomography/Computed Tomography (PET/CT) scan.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- 68Ga-FAPI PET/CT in Patients With Various Types of Cancer#841942
- Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders#1059894
- 18F-FMAU PET/CT in Imaging Patients With Advanced Cancers#803935
- Characterizing Spondyloarthritis With 68Ga-FAPI PET/CT#826950
- Imaging 61CuATSM Uptake in Atherosclerotic Plaque Using PET-CT#918852
Record · ID 887562
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive